Headquartered in San Francisco, CA Fiscal year ends March NYSE: DOCS doximity.com
Doximity is a digital platform for U.S. medical professionals, with a network that includes more than 85% of U.S. physicians across all specialties and practice areas. Founded in 2010, the company provides verified clinical members with digital tools for collaboration, medical news and research, career management, on-call scheduling, documentation streamlining, and virtual patient visits. Doximity has expanded into AI-powered clinical tools, including Doximity Ask (a HIPAA-compliant generative AI clinical research and writing assistant), AI Search for medical literature, PeerCheck for AI-reviewed content, Amion for on-call scheduling, and Scribe for HIPAA-compliant ambient clinical note-taking. The company generates revenue primarily through subscription-based services sold to pharmaceutical and health systems customers. Doximity trades on the NYSE under the ticker DOCS. Updated
Apple just got slapped with an Underperform rating while Trade Desk faces a brutal price target, but some names on Monday's analyst radar are picking up surprise upgrades that could shift the…
Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters in the telehealth sector’s short history, and bargain hunters are circling the…
Healthcare AI stocks have been hammered in 2026, with several names down 30% to 65% year to date even as their underlying platforms keep maturing. That dislocation between share price and product…
Pre-Market Stock Futures: Futures are trading sharply lower as we get set to end one of the most exciting weeks on Wall Street in 25 years. Positive meetings in China with President…
Pre-Market Stock Futures: Futures are trading higher on Thursday after another wild day on Wall Street, during which the major indices moved in different directions. Another round of disturbing inflation data hit…
Live Updates Doximity Q4 Earnings Coverage Wrap-Up4:37pm ETThat wraps up our initial coverage of Doximity’s Q4 results. Thank you for stopping by! Check out management’s earnings call at 5 PM EST for…
Thomas Richmond Pre-Market Stock Futures: The futures are exploding higher, as, fortunately, President Trump chose not to “end civilization in Iran” and agreed to a two-week pause on attacks on Iran. In contrast, Iran…
Pre-Market Stock Futures: Futures are trading lower after an incredible turnaround on Friday, with all major indices surging higher following a three-day massive sell-off that had pushed the stock market to the…
Pre-Market Stock Futures: Futures are trading dramatically lower as we start the holiday-shortened trading week, following yesterday’s MLK remembrance day. The futures downdraft this morning is being attributed to President Trump’s threat…
Pre-Market Stock Futures: The futures are trading modestly higher as we get set to wrap up the first complete trading week of 2026, which could finish with a bang today. With market-moving…
Pre-Market Stock Futures: The futures are trading lower as we begin the final trading week of 2025, albeit a holiday-shortened one once again. The major indices all finished the session modestly lower…
Analysts at Jefferies are pounding the table over Viking Holdings (NYSE: VIK | VIK Price Prediction). Even after the VIK stock rallied from about $57.50 to $68.75, Jefferies sees more upside ahead.…
Pre-Market Stock Futures: The futures are trading flat on Tuesday after we opened the week on the downside, with all major indices finishing the day lower. With the Federal Reserve meeting this…
After swinging in red just yesterday, the major indices are regaining lost momentum. All after the Federal Reserve President John Williams suggested that the central bank cut rates in December. He believes…
British billionaire investor Terry Smith is known as “the English Warren Buffett.” His London-based investment management firm, Fundsmith, was founded in 2010 and is known for Smith’s disciplined, long-term approach to investing.…
Doximity is a digital platform for U.S. medical professionals, with a network that includes more than 85% of U.S. physicians across all specialties and practice areas.
24/7 Wall St.'s 12-month price target for DOCS is $34.71, rated Buy. The Wall Street consensus target is $29.67. DOCS price prediction →
